Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Kalvista Pharmaceuticals Inc

KALV
Current price
11.54 USD -0.21 USD (-1.79%)
Last closed 11.84 USD
ISIN US4834971032
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 533 279 264 USD
Yield for 12 month +27.65 %
1Y
3Y
5Y
10Y
15Y
KALV
21.11.2021 - 28.11.2021

KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, engages in the discovery, development, and commercialization of drug therapies inhibitors for diseases with unmet needs. The company's product candidate is Sebetralstat, a small molecule plasma kallikrein inhibitor targeting the disease of hereditary angioedema (HAE). It develops Factor XIIa, an oral inhibitor for the treatment of HAE which is in preclinical trial. In addition, the company is developing an orally disintegrating tablet formulation, including KONFIDENT-KID for pediatric use with HAE; KONFIDENT-S for adolescent and adult patients with type I or type II HAE; and KONFIDENT for a potential oral therapy for HAE attacks. The company is headquartered in Cambridge, Massachusetts. Address: 55 Cambridge Parkway, Cambridge, MA, United States, 02142

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

30.17 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

+1 206 000 USD

Current Year

-816 000 USD

Last Year

-802 000 USD

Current Quarter

-224 000 USD

Last Quarter

+987 000 USD

Key Figures KALV

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -154 720 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -53.94 %
PEG Ratio
Return On Equity TTM -90.84 %
Wall Street Target Price 30.17 USD
Revenue TTM 3 824 000 USD
Book Value 4.01 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 30.7 %
Dividend Yield
Gross Profit TTM -80 276 000 USD
Earnings per share -3.57 USD
Diluted Eps TTM -3.57 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics KALV

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History KALV

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:14
Payout Ratio
Last Split Date 22.11.2016
Dividend Date 22.11.2016

Stock Valuation KALV

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 76.3323
Price Sales TTM 107.4168
Enterprise Value EBITDA -3.5261
Price Book MRQ 3.0861

Financials KALV

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators KALV

For 52 weeks

7.21 USD 16.88 USD
50 Day MA 12.49 USD
Shares Short Prior Month 5 645 899
200 Day MA 12.43 USD
Short Ratio 18.98
Shares Short 5 719 246
Short Percent 15.24 %